(5-Methyl-1,3-dioxolen-2-on-4-ylmethyl) 7-[D-O-(L-alanyl)mandelamido]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl]-3-cephem-4-carboxylate hydrochloride (5-Methyl-2-oxo-1,3-dioxo-4-yl)methyl (6R,7R)-7-[(R)-2-[(S)-alanyloxy]-2-phenylacetamido]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydroch (6R,7R)-7beta-[2(R)-(S-Alanyloxy)-2-phenylacetamido]-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 2,3-Dihydroxy-2-butenyl (6R,7R)-7-[(R)-mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,cyclic-2,3-carbonate,ester with L-alanine m 92602-21-6 CEFCANEL DALOXATE HYDROCHLORIDE Cefcanel daloxate hydrochloride < Rec INNM > D04KHH Enylethyl ester monohydrochloride KY-109 L-Alanine [6R-[6alpha,7beta(R*)]]-2-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-2-oxo-1-ph Loride Onohydrochloride
| CAS 号 | 92602-21-6 |
| 分子式 | C27H27N5O9S3 Cl H |
| 分子量 | N/A g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
CAS 92602-21-6 对应的((5-Methyl-1,3-dioxolen-2-on-4-ylmethyl) 7-[D-O-(L-alanyl)mandelamido]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl]-3-cephem-4-carboxylate hydrochloride (5-Methyl-2-oxo-1,3-dioxo-4-yl)methyl (6R,7R)-7-[(R)-2-[(S)-alanyloxy]-2-phenylacetamido]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydroch (6R,7R)-7beta-[2(R)-(S-Alanyloxy)-2-phenylacetamido]-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 2,3-Dihydroxy-2-butenyl (6R,7R)-7-[(R)-mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,cyclic-2,3-carbonate,ester with L-alanine m 92602-21-6 CEFCANEL DALOXATE HYDROCHLORIDE Cefcanel daloxate hydrochloride < Rec INNM > D04KHH Enylethyl ester monohydrochloride KY-109 L-Alanine [6R-[6alpha,7beta(R*)]]-2-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-2-oxo-1-ph Loride Onohydrochloride)为 CATO 佳途药物标准品产品线成员。分子式 C27H27N5O9S3 Cl H。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认,质量稳定可溯源。
(C27H27N5O9S3 Cl H)含有含氮杂环结构,酰胺类,含砜基,含羟基,含醚键,含氯取代。具有较强的吸湿性,卤素取代增加了化合物的密度和沸点,羧基赋予其一定的酸性特征,这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。分子中的氮原子赋予该化合物一定的碱性特征,在酸性流动相条件下可被有效质子化。 ((5-Methyl-1,3-dioxolen-2-on-4-ylmethyl) 7-D-O-(L-alanyl)mandelamido-3-(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylate hydrochloride (5-Methyl-2-oxo-1,3-dioxo-4-yl)methyl (6R,7R)-7-(R)-2-(S)-alanyloxy-2-phenylacetamido-3-(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carbo
应用场景:针对化学分析用途,((5-Methyl-1,3-dioxolen-2-on-4-ylmethyl) 7- D-O-(L-alanyl)mandelamido -3- (5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl -3-cephem-4-carboxylate hydrochloride (5-Methyl-2-oxo-1,3-dioxo-4-yl)methyl (6R,7R)-7- (R)-2- (S)-alanyloxy -2-phenylacetamido -3- (5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl
| 中文名称 | |
| 分子式 | C27H27N5O9S3 Cl H |
| 分子量 | 698.18 g/mol |
| 外观形态 | 淡黄色至黄色无定形粉末。(具有轻微卤代物特征气味,含硫化合物特征性气味) |
| 纯度 | 97%+ |
| 储存条件 | 阴凉处(≤25°C)保存,避光,密封防潮 |
| 溶解性参考 | 可溶于DMSO、DMF、甲醇 |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封;含酯键,遇强碱易水解 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 16.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份(估) | 1983年 |
| 卤素含量 | Cl取代 |
| 含氮原子数 | 5 |
| 含硫原子数 | 3 |